These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 34116674)

  • 21. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
    Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial Effect of the SGLT2 Inhibitor Empagliflozin on Glucose Homeostasis and Cardiovascular Parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) Rat.
    Younis F; Leor J; Abassi Z; Landa N; Rath L; Hollander K; Naftali-Shani N; Rosenthal T
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):358-371. PubMed ID: 29627992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
    Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
    Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
    Lee HC; Shiou YL; Jhuo SJ; Chang CY; Liu PL; Jhuang WJ; Dai ZK; Chen WY; Chen YF; Lee AS
    Cardiovasc Diabetol; 2019 Apr; 18(1):45. PubMed ID: 30935417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy.
    Yang Z; Li T; Xian J; Chen J; Huang Y; Zhang Q; Lin X; Lu H; Lin Y
    FASEB J; 2022 Jul; 36(7):e22410. PubMed ID: 35713937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoid X receptor agonists alleviate fibroblast activation and post-infarction cardiac remodeling via inhibition of TGF-β1/Smad pathway.
    Lin XY; Chu Y; Zhang GS; Zhang HL; Kang K; Wu MX; Zhu J; Xu CS; Lin JX; Huang CK; Chai DJ
    Life Sci; 2023 Sep; 329():121936. PubMed ID: 37453576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
    Yurista SR; Silljé HHW; Oberdorf-Maass SU; Schouten EM; Pavez Giani MG; Hillebrands JL; van Goor H; van Veldhuisen DJ; de Boer RA; Westenbrink BD
    Eur J Heart Fail; 2019 Jul; 21(7):862-873. PubMed ID: 31033127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1/AMPK/PGC1α/FoxO1 axis.
    Hassan HA; Nageeb MM; Mohammed HO; Samy W; Fawzy A; Afifi R; Abbas NAT
    Toxicol Appl Pharmacol; 2024 Aug; 489():116991. PubMed ID: 38871090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury.
    Lahnwong C; Palee S; Apaijai N; Sriwichaiin S; Kerdphoo S; Jaiwongkam T; Chattipakorn SC; Chattipakorn N
    Cardiovasc Diabetol; 2020 Jun; 19(1):91. PubMed ID: 32539724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro.
    Zhang J; Fu X; Yang L; Wen H; Zhang L; Liu F; Lou Y; Yang Q; Ding Y
    Biomed Pharmacother; 2020 Sep; 129():110364. PubMed ID: 32531678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermedin alleviates pathological cardiac remodeling by upregulating klotho.
    Zhang LS; Liu Y; Chen Y; Ren JL; Zhang YR; Yu YR; Jia MZ; Ning ZP; Du J; Tang CS; Qi YF
    Pharmacol Res; 2020 Sep; 159():104926. PubMed ID: 32502636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High glucose-induced Smad3 linker phosphorylation and CCN2 expression are inhibited by dapagliflozin in a diabetic tubule epithelial cell model.
    Pan X; Phanish MK; Baines DL; Dockrell MEC
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34003249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation.
    Li PF; He RH; Shi SB; Li R; Wang QT; Rao GT; Yang B
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective role of berberine in isoprenaline-induced cardiac fibrosis in rats.
    Che Y; Shen DF; Wang ZP; Jin YG; Wu QQ; Wang SS; Yuan Y
    BMC Cardiovasc Disord; 2019 Oct; 19(1):219. PubMed ID: 31615408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.
    Li X; Lu Q; Qiu Y; do Carmo JM; Wang Z; da Silva AA; Mouton A; Omoto ACM; Hall ME; Li J; Hall JE
    J Am Heart Assoc; 2021 Mar; 10(6):e018298. PubMed ID: 33719499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-
    Liu L; Luo H; Liang Y; Tang J; Shu Y
    Comput Math Methods Med; 2022; 2022():3293054. PubMed ID: 35096128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linggui Zhugan Decoction () Inhibits Ventricular Remodeling after Acute Myocardial Infarction in Mice by Suppressing TGF-β
    Wang L; Shi H; Huang JL; Xu S; Liu PP
    Chin J Integr Med; 2020 May; 26(5):345-352. PubMed ID: 30623345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.